Okeanis Eco Tankers Corp.
Contacts
Company:
Iraklis Sbarounis, CFO
Tel: +30 210 480 4200
[email protected]
Investor Relations / Media Contact:
Nicolas Bornozis, President
Capital Link, Inc.
230 Park Avenue, Suite 1540, New York, N.Y. 10169
Tel: +1 (212) 661-7566
[email protected]
About OET
OET is a leading international tanker company providing seaborne transportation of crude oil and refined products. The Company was incorporated on April 30, 2018 under the laws of the Republic of the Marshall Islands and is listed on Oslo Stock Exchange under the symbol OET and the New York Stock Exchange under the symbol ECO. The sailing fleet consists of six modern scrubber-fitted Suezmax tankers and eight modern scrubber-fitted VLCC tankers.
Forward-Looking Statements
This communication contains 'forward-looking statements', including as defined under U.S. federal securities laws. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements include statements about the Company's expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts or that are not present facts or conditions. Words or phrases such as 'anticipate,' 'believe,' 'continue,' 'estimate,' 'expect,' 'hope,' 'intend,' 'may,' 'ongoing,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'will' or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. The Company's actual results could differ materially from those anticipated in forward-looking statements for many reasons, including as described in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'). Accordingly, you should not unduly rely on these forward-looking statements, which speak only as of the date of this communication. Factors that could cause actual results to differ materially include, but are not limited to, the Company's operating or financial results; the Company's liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations; broader market impacts arising from war (or threatened war) or international hostilities; risks associated with pandemics, including effects on demand for oil and other products transported by tankers and the transportation thereof; and other factors listed from time to time in the Company's filings with the SEC. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based. You should, however, review the factors and risks the Company describes in the reports it files and furnishes from time to time with the SEC, which can be obtained free of charge on the SEC's website at www.sec.gov.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
England international agrees to join Liverpool
Liverpool are facing a contract problem with . The French defender is out of contract in 2026 and if no agreement over a new deal is reached then he will be leaving on a free next summer. That would be a bitter blow for sporting director Richard Hughes - with the Reds having invested around £35m in Konate back in 2021. 🔴 Shop the LFC 2025/26 adidas home range 🚨2025/26 LFC x adidas range🚨 LFC x adidas Shop the home range today! LFC x adidas Shop the goalkeeper range today LFC x adidas Shop the new adidas range today! The 26-year-old joined from RB Leipzig but it was only last season that he truly emerged as a world-class talent alongside Virgil van Dijk. 🔴 Shop the LFC 2025/26 adidas away range With so much uncertainty over Konate - who has been mentioned as a potential sale this summer if no contract is signed - it's no wonder Liverpool are considering alternatives. Liverpool linked with Marc Guehi Although the club signed Giovanni Leoni for £26m from Parma last week, it remains to be seen just how much football the 18-year-old gets through in his rookie season. Accordingly, senior options have been discussed and Marc Guehi looks the ideal candidate in that respect. Like Konate, the Crystal Palace captain is out of contract in 2026 and he too could be departing on a free. Of course Palace are against that idea and if a team comes up with the asking price during this transfer window - said to be £40m - then he too would be on his way. Guehi pledges to join ONLY Liverpool Liverpool seem content to wait although expect them to strike if they get the idea that a deal is in reach before the end of the window. Now according to the Athletic, the Reds have got one less thing to worry about. That's because Guehi has assured the Reds that it's Anfield or nothing - and that he is currently NOT interested in a move elsewhere. The 25-year-old England international has earmarked a move ONLY to the Premier League champions. © IMAGO - Marc Guehi Liverpool Guehi has eyes only for Liverpool "If he leaves Palace now, Guehi only has eyes for Liverpool, who believe they already possess four elite central defenders, so are not expected to seek an alternative if they fail to land the 25-year-old,' the report reads. This stance would appear to tally with other reports concerning the former Chelsea player. Liverpool can be optimistic of landing Guehi for around £40m this summer or else bringing him in on a free in 2026. He may well be a replacement for Konate in time - should the Frenchman fail to renew his deal - but having lost Jarell Quansah and given Joe Gomez's injury record, Arne Slot could do a lot worse than add centre-back depth.
TechCrunch
12 minutes ago
- TechCrunch
Sony is increasing the price of the PlayStation 5 as new tariffs take hold
Sony will raise the price of PlayStation 5 consoles, the company announced on Wednesday. These changes will be effective as of Thursday, August 21. Citing 'a challenging economic environment' — which appears to reference President Trump's tariffs on imported products — Sony is increasing console prices by about $50. In the U.S., the prices will increase to $549.99 for the PlayStation 5, $499.99 for the PlayStation 5 Digital Edition, and $749.99 for the PlayStation 5 Pro. On July 31, the White House announced a 15% tariff on Japan. The company said that it does not have plans to change prices in other countries, nor does it intend to hike the cost of accessories. However, Sony already raised prices for PlayStation consoles sold in Europe, Australia, and New Zealand in April, citing the same challenging environment. In some regions, Sony previously increased console prices in 2022 due to inflation, but U.S. markets were not impacted at the time. Some of Sony's peers have also announced pricing changes to gaming products amid the news of Trump's tariffs. Microsoft indicated in May that it would increase console prices by $80 to $100, while also increasing the prices of some games, controllers, and accessories. Nintendo chose to raise the prices of some accessories for the new Nintendo Switch 2 console, but not the console itself.
Yahoo
40 minutes ago
- Yahoo
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its 'GROW' strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwill of ~16%. Novonesis is well positioned to continue to drive strong performance in biosolutions. The company is present across multiple end-markets with strong capabilities to deliver value-adding solutions for tailored customer needs. Novonesis' distinct position is built on three capabilities: deep customer understanding, unparalleled innovation and an exceptional ability to scale and produce robust and affordable biosolutions. In a world with a growing population, increasing energy needs, evolving nutritional and health trends, as well as climate risks, the company sees a strong and increasing demand for biosolutions. Ester Baiget, President & CEO: 'We are clearly on track to deliver on our 2025 targets that were set when we announced the combination. The potential for biosolutions continues to be strong and Novonesis is uniquely positioned to achieve accelerated profitable growth towards 2030 and beyond. We focus on growing our core, where we continue to see strong demand, and we significantly invest in our distinct capabilities to further expand our market and innovation leadership. We believe the more we grow, the more long-term value and impact we create for shareholders, customers, people and the planet.' Novonesis' proven growth matrix is a well-balanced combination of end-market volume growth, pricing, upselling and adjacencies, as well as penetration. The company continues to explore areas with long-term growth opportunities targeting applications and markets with significant untapped potential. The new explorative areas in focus are Biopharma Processing Aids, Future Fuels and Chemicals, and Functional Food Proteins. 2030 targets* Organic sales growth CAGR of 6-9%. The organic sales growth is expected to be mainly driven by volume, including synergies, as well as an annual price contribution between 1-2%. Both the Food & Health and Planetary Health Biosolutions divisions are expected to grow within the Group range, and emerging markets are expected to grow stronger than developed markets. An adjusted EBITDA margin expected at around 39% by 2030, based on current currency exchange rates. The strategy period includes synergies, as well as significant investments in innovation, commercial and go-to-market capabilities to support growth on both the short- and long-term time horizons. The adjusted ROIC excl. goodwill is expected at around 16% by 2030, increasing from pro forma 8.3% in 2024. A reconfirmation of non-financial ambitions and targets, with investments to realize these targets. Modeling assumptions* Capex as a percentage of sales will be elevated at the beginning of the strategy period to cater for sustained high growth, also beyond the strategy period. A new ERP system and investments to support sustainability efforts are also included in the Capex. We invest globally to cater for increasing demand, creating flexibility on a global and regional basis. The Capex level will gradually decrease to high-single-digit as a percent of sales towards the end of the strategy period. A net debt/EBITDA ratio is targeted at around 1.5x in alignment with the capital allocation policy. A continued clear capital allocation model with an expected dividend payout ratio of 40-60% of adj. net profit. The 2030 strategy will be presented and commented on in combination with the extended H1 2025 conference call on August 21 at 09.00 CET. Slides will be shared ahead of the conference call. * 2025 as a baseline. All targets assume constant currencies, no impact from acquisitions or divestments, no major changes or disruptions to the current state of the global economy, including global trade conditions. Contact information Investor Relations Tobias Bjorklund, +45 3077 8682, tobb@ Anders Enevoldsen, +45 5350 1453, adev@ Katrine Spedtsberg Poulsen, kats@ Media Relations Jens Gamborg, +45 3077 7182, jgam@ Forward-looking statements This announcement includes forward-looking statements, including statements relating to the operating, financial and sustainability performance and results of the group and/or the industry in which it operates. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as "aim", "anticipate", "assess", "assume", "believe", "continue", "could", "estimate", "expect", "goal", "hope", "intend", "may", "objective", "plan", "position", "potential", "predict", "project", "risk", "seek", "should", "target", "will", "would", or any variations of such words or other words with similar meanings. Any such statements are subject to risks and uncertainties that could cause the group's actual results to differ materially from the results discussed in such forward-looking statements. Prospective information is based on management's then current expectations or forecasts. Such information is subject to the risk that such expectations or forecasts, or the assumptions underlying such expectations or forecasts, may change. Unless as required by applicable laws, the group assumes no obligation to update any such forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. Factors that could cause the group's actual results to differ materially from those expressed in its forward-looking statements include, but are not limited to: i) unexpected developments in the ability to develop and market new products; ii) fluctuations in the demand for the group's products, market-driven price decreases, industry consolidation, and launches of competing products or disruptive technologies in the group's core business areas; iii) changes in the ability to protect and enforce the company's intellectual property rights; iv) significant litigation or breaches of contract; v) the materialization of the company's growth platforms; vi) political conditions, such as acceptance of enzymes produced by genetically modified organisms; vii) global economic and capital market conditions, including, but not limited to, currency exchange rates (USD/DKK and EUR/DKK in particular, but not exclusively), interest rates, and inflation; viii) significant price decreases for input and other materials that compete with the group's solutions; and ix) changes in laws or interpretations thereof, including those related to reimbursement, intellectual property protection, marketing, and taxation (including tariffs and duties). New risk factors can arise, and it may not be possible for management to predict all such risk factors, nor to assess the impact of all such risk factors on the group's business or the extent to which any individual risk factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as predictions of actual future events or in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
